A detailed history of Waterloo Capital, L.P. transactions in Pfizer Inc stock. As of the latest transaction made, Waterloo Capital, L.P. holds 20,232 shares of PFE stock, worth $572,565. This represents 0.07% of its overall portfolio holdings.

Number of Shares
20,232
Previous 61,394 67.05%
Holding current value
$572,565
Previous $1.7 Billion 66.77%
% of portfolio
0.07%
Previous 0.22%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$25.26 - $29.6 $1.04 Million - $1.22 Million
-41,162 Reduced 67.05%
20,232 $566 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $389,540 - $447,317
15,046 Added 32.46%
61,394 $1.7 Billion
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $1.21 Million - $1.57 Million
46,348 New
46,348 $1.33 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $159B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Waterloo Capital, L.P. Portfolio

Follow Waterloo Capital, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waterloo Capital, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Waterloo Capital, L.P. with notifications on news.